Abstract
Aneuploidy is one of the major hallmarks of cancer cells and several paths towards aneuploidy have been described. However, the relevance for tumor initiation or progression and how tumors deal with the initial aneuploidy related stress response is still unclear and recent results suggest that aneuploidy can even have tumor suppressive effects under certain conditions. The molecular mechanisms leading to and sustaining growth of aneuploid cells are just at the beginning to be understood and might provide new targets for cancer drug development. We will discuss some of the ideas to specifically kill aneuploid cells by targeting key regulators of mitosis.
Keywords: Aneuploidy, mitotic checkpoint, centrosomes, mitotic kinases, cell cycle, cancer therapy, Tumor, Mitotoic kinases, Chromosome, Polyploidy, Mitosis, Kinetochores, Chromosomal segregation, Cytokinesis, Mitotic spindles, Drosophila, Tumorigenesis, voracious appetite, Infection, Human papilloma virus, Aurora kinases, Endoreduplication, Cell fusion, Syncytia, HIV, Microsatellite instability, Trisomies, Proteasomes, Tumor supporessor genes, Targeting mitotic kinases, Pan-Aurora, Kinase inhibitor danusertib (PHA-739358), SAC inhibitors, HTLV-1 virus
Current Drug Targets
Title: Destabilizing Aneuploidy by Targeting Cell Cycle and Mitotic Checkpoint Proteins in Cancer Cells
Volume: 11 Issue: 10
Author(s): Riccardo Colombo and Jurgen Moll
Affiliation:
Keywords: Aneuploidy, mitotic checkpoint, centrosomes, mitotic kinases, cell cycle, cancer therapy, Tumor, Mitotoic kinases, Chromosome, Polyploidy, Mitosis, Kinetochores, Chromosomal segregation, Cytokinesis, Mitotic spindles, Drosophila, Tumorigenesis, voracious appetite, Infection, Human papilloma virus, Aurora kinases, Endoreduplication, Cell fusion, Syncytia, HIV, Microsatellite instability, Trisomies, Proteasomes, Tumor supporessor genes, Targeting mitotic kinases, Pan-Aurora, Kinase inhibitor danusertib (PHA-739358), SAC inhibitors, HTLV-1 virus
Abstract: Aneuploidy is one of the major hallmarks of cancer cells and several paths towards aneuploidy have been described. However, the relevance for tumor initiation or progression and how tumors deal with the initial aneuploidy related stress response is still unclear and recent results suggest that aneuploidy can even have tumor suppressive effects under certain conditions. The molecular mechanisms leading to and sustaining growth of aneuploid cells are just at the beginning to be understood and might provide new targets for cancer drug development. We will discuss some of the ideas to specifically kill aneuploid cells by targeting key regulators of mitosis.
Export Options
About this article
Cite this article as:
Colombo Riccardo and Moll Jurgen, Destabilizing Aneuploidy by Targeting Cell Cycle and Mitotic Checkpoint Proteins in Cancer Cells, Current Drug Targets 2010; 11 (10) . https://dx.doi.org/10.2174/1389450111007011325
DOI https://dx.doi.org/10.2174/1389450111007011325 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Peptide Nucleic Acids with a Structurally Biased Backbone. Updated Review and Emerging Challenges
Current Topics in Medicinal Chemistry Carbon Nanotubes: Classification, Method of Preparation and Pharmaceutical Application
Current Drug Delivery Recent Advances In Developing Novel Anti-Cancer Drugs Targeting Tumor Hypoxic and Acidic Microenvironments
Recent Patents on Anti-Cancer Drug Discovery Let-7 miRNA Precursors Co-express with LIN28B in Cervical Cells
MicroRNA Nicotine Vaccines
CNS & Neurological Disorders - Drug Targets Regulation of EMT by Notch Signaling Pathway in Tumor Progression
Current Cancer Drug Targets The Interest of Folic Acid in Targeted Photodynamic Therapy
Current Medicinal Chemistry Translation of a Tissue-Selective Rexinoid, UAB30, to the Clinic for Breast Cancer Prevention
Current Topics in Medicinal Chemistry T Cell Replicative Senescence in Human Aging
Current Pharmaceutical Design Vaccines and Other Immunological Approaches for Cancer Immunoprevention
Current Drug Targets Development of Anticancer Agents from Plant-Derived Sesquiterpene Lactones
Current Medicinal Chemistry Exploring the Role of Phytochemicals as Potent Natural Photosensitizers in Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Monotherapy for the Treatment of Lymphedema in Children: A Review
Current Pediatric Reviews P-Selectin Glycoprotein Ligand-1 as a Potential Target for Humoral Immunotherapy of Multiple Myeloma (Supplementry Material)
Current Cancer Drug Targets Solvent-Free Synthesis of New 3’H-spiro[indole-3,2’-[1,3]]benzothiazole- 2(1H)-one Derivatives Using Michael Reaction
Letters in Organic Chemistry Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies
Current Molecular Medicine Anti-Cancer Phytometabolites Targeting Cancer Stem Cells
Current Genomics Theranostics Based on Iron Oxide and Gold Nanoparticles for Imaging- Guided Photothermal and Photodynamic Therapy of Cancer
Current Topics in Medicinal Chemistry Phase 1 Clinical Experience Using Intravenous Administration of PV701, an Oncolytic Newcastle Disease Virus
Current Cancer Drug Targets Recent Advancement in Discovery and Development of Natural Product Combretastatin-inspired Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry